Zacks Investment Research on MSN

Editas Medicine (EDIT) Reports Q3 Loss, Beats Revenue Estimates

Editas Medicine (EDIT) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to a loss of $0.75 per share a year ago. These figures ...
Nasdaq

Editas Medicine (EDIT) Reports Q1 Loss, Tops Revenue Estimates

Editas Medicine (EDIT) came out with a quarterly loss of $0.43 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to loss of $0.76 per share a year ago. These figures are ...